Key Statistics
Market Cap$760.52M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.18
52W High$12.49
52W Low$5.41
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees260
Price Performance
1 Week+11.24%
3 Month-9.75%
1 Year+39.55%
FinancialsAnnual · QuiverQuant
Revenue—
Assets$448.94M
Liabilities$51.66M
Net Income$152.63M loss
About
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze KURA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.